[HTML][HTML] Prevalence of human papillomavirus (HPV) infections in sexually active adolescents and young women in England, prior to widespread HPV immunisation

R Howell-Jones, N de Silva, M Akpan, P Oakeshott… - Vaccine, 2012 - Elsevier
INTRODUCTION: The introduction of an HPV immunisation programme in England should
result in a significant reduction in the prevalence of vaccine type infections in young women …

Strongly decreased risk of genital warts after vaccination against human papillomavirus: nationwide follow-up of vaccinated and unvaccinated girls in Denmark

M Blomberg, C Dehlendorff, C Munk… - Clinical infectious …, 2013 - academic.oup.com
Background. A reduction in the incidence of genital warts (GWs) is one of the first markers of
the effectiveness of vaccination against human papillomavirus (HPV) at the population level …

Human papillomavirus vaccination in the United Kingdom: what about boys?

T Kubba - Reproductive health matters, 2008 - Taylor & Francis
In September 2008 the UK Department of Health initiated a human papillomavirus (HPV)
immunisation programme for girls aged 12–13 for prevention of cervical cancer, which is …

Prevalence of human papillomavirus in teenage heterosexual males following the implementation of female and male school-based vaccination in Australia: 2014 …

EPF Chow, SN Tabrizi, CK Fairley, R Wigan… - Vaccine, 2019 - Elsevier
Background Australia introduced a school-based human papillomavirus (HPV) vaccination
program for females aged 12–13 years in 2007, with a three-year catch-up to age 26; and for …

Very low prevalence of vaccine human papillomavirus types among 18-to 35-year old Australian women 9 years following implementation of vaccination

DA Machalek, SM Garland… - The Journal of …, 2018 - academic.oup.com
Introduction A quadrivalent human papillomavirus vaccination program targeting females
aged 12–13 years commenced in Australia in 2007, with catch-up vaccination of 14–26 year …

[HTML][HTML] The impact of HPV multi-cohort vaccination: real-world evidence of faster control of HPV-related morbidity

M Orumaa, SK Kjaer, C Dehlendorff, C Munk, AO Olsen… - Vaccine, 2020 - Elsevier
Abstract Background In 2009, both Norway and Denmark initiated routine quadrivalent
human papillomavirus vaccination (qHPV) for 12-year-old girls; however, Denmark also …

Genital warts incidence and healthcare resource utilisation in Australia

M Pirotta, AN Stein, EL Conway, C Harrison… - Sexually transmitted …, 2010 - sti.bmj.com
Objectives To estimate for the first time the incidence and healthcare resource utilisation
associated with genital warts (GW) in Australia prior to the human papillomavirus …

Adolescent and young adult HPV vaccination in Australia: achievements and challenges

SM Garland, SR Skinner, JML Brotherton - Preventive medicine, 2011 - Elsevier
Australia commenced an ongoing school based government funded human
papillomaviruses (HPV)(cervical cancer prevention) vaccination program in April 2007 for …

Assessing genital human papillomavirus genoprevalence in young Australian women following the introduction of a national vaccination program

SL Osborne, SN Tabrizi, JML Brotherton, AM Cornall… - Vaccine, 2015 - Elsevier
Objectives Following the implementation of Australia's National HPV Vaccination Program in
April 2007, this study evaluated the prevalence of vaccine-targeted human papillomavirus …

Genital warts and cost of care in England

S Desai, S Wetten, SC Woodhall, L Peters… - Sexually transmitted …, 2011 - sti.bmj.com
Objectives To estimate the total number of cases of, and cost of care for, genital warts (GWs)
in England, to inform economic evaluations of human papillomavirus vaccination. Methods …